RxDoctor Payments Data

Savita Collins, MD

Otolaryngology · Goshen, INNPI 1245257856

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,215 of the $8,284 with a category attached, or 63.0%. 11 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 39.9% of the total. Reporting peaked in 2024 at $3,620 and has fallen 64.0% since, to $1,303 in 2025.

$8,284in general payments, 2019–2025

Across 166 payments — averaging $49.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$3K
  • Smith+Nephew$3K
  • Stryker$1K
  • GSK$325
  • Baxter Healthcare$112
  • Novartis$34
  • plus $110 from 5 others

What the payments were for

  • Travel & lodging$3,06937%
  • Food & beverage$5,21563%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,284 in reported general payments places this provider in the 85th percentile of 193 otolaryngology providers in Indiana.

See all otolaryngology providers in Indiana

Medicare billing

Part B allowed, 2024
$52,242
Medicare patients
201
Services billed
501

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl74$2,010
Ofloxacin44$1,165
Cefdinir25$699
Ipratropium Bromide24$513
Fluticasone Propionate32$251
Omeprazole23$172
Famotidine21$108
Montelukast Sodium16$103
Methylprednisolone13$76
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$74
Prednisone16$30

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Goshen

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →